Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis

Journal of Clinical Oncology

Volumn 19, Issue 7, 2001, Pages 2026-2032

  Rueffer, U ^a   Josting, A ^a   Franklin, J ^a   May, M ^a   Sieber, M ^a   Breuer, K ^a   Engert, A ^a   Diehl, V ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; GERMANY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER;

EID: 0035300679     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.7.2026     Document Type: Article

References (21)

1. The management of Hodgkin's disease: Half a century of change
2. Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age
3. Second cancer after the treatment for Hodgkin's disease: A report from the international database on Hodgkin's disease
4. Leukemia following Hodgkin's disease
5. Risk of second cancers after treatment for Hodgkin's disease
6. Second cancer risk following Hodgkin's disease: A 20-year follow-up study
7. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment
8. Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: A 20-year experience
9. Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: A clinico-pathological and immuno-histochemical population-based study of 32 patients
10. Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121 patients from a single institution
11. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease
12. Non-parametric estimation from incomplete observations
13. A predictive model for aggressive Non Hodgkin's lymphoma: The International Non Hodgkin's Lymphoma Prognostic Factors Project
14. Non Hodgkin's lymphoma arising in patients successfully treated for Hodgkin's disease: A clinical, histologic, and immunophenotypic study of 14 cases
15. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome
16. Second acute leukemia and other malignancies following treatment for Hodgkin's disease
17. Late complications after Hodgkin's disease
18. Clinical characteristics of non-Hodgkin's lymphoma as a second primary tumor: A population-based survey
19. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease
20. Risk of second primary cancer after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation
21. Prognostic factors and treatment outcome in patients with primary progressive Hodgkin's lymphoma: A report from the German Hodgkin's Lymphoma Study Group (GHSG)